PDGF-B gene single-nucleotide polymorphisms are not predictive for disease onset or progression of IgA nephropathy

Clinical Nephrology

Volumn 67, Issue 2, 2007, Pages 65-72

  Bicanski, Bojan ^a   Wenderdel, M ^a   Mertens, Peter R ^a   Senderek, J ^a   Panzer, U ^b   Steinmetz, O ^b   Stahl, R A K ^b   Cerullo, G ^c   Diletta Torres, D ^c   Schena, F P ^c   Zerres, K ^a   Floege, J ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Glomerulonephritis; Growth factors; IgA nephropathy; PDGH; Progression

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR B;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG RESPONSE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; GERMANY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; ITALY; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PREDICTION; PROTEINURIA; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33847316462     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP67065     Document Type: Article

References (22)

1. Alpers CE, Seifert RA, Hudkins KL et al. Developmental patterns of PDGF B-chain, PDGF-receptor and alpha-actin expression in human glomerulogenesis. Kidney Int. 1992; 42: 390-399.
2. Alpers CE, Seifert RA, Hudkins KL et al. PDGF receptor localizes to mesangial, parietal epithelial and interstitial cells in human and primate kidneys. Kidney Int. 1993; 43: 286-294.
3. Bantis C, Heering PJ, Aker S et al. Influence of beta3 integrin gene Leu/ Pro33 polymorphism on primary glomerulonephritis. Nephron Exp Nephrol. 2005; 99: e33-37.
4. Berthoux FC, Berthoux P, Mariat C et al. CC chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32bp deletion alleles associated with late progression to end-stage renal failure with dialysis. Kidney Int. 2006; 69: 565-572.
5. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24: 179-196.
6. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002; 347: 738-748.
7. Floege J, Feehally J. IgA nephropathy: recent developments. J Am Soc Nephrol. 2000; 11: 2395-2403.
8. Floege J, Johnson RJ. Multiple roles for platelet-derived growth factor in renal disease. Miner Electrolyte Metab. 1995; 21: 271-282.
9. Gesualdo L, Di Paolo S, Milani S et al. Expression of platelet-derived growth factor receptors in normal and diseased human kidney. An immunohistochemistry and in situ hybridization study. J Clin Invest. 1994; 94: 50-58.
10. Gesualdo L, Pinzani M, Floriano JJ et al. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab Invest. 1991; 65: 160-167.
11. Gharavi A G, Yan Y, Scolari F et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet. 2000; 26: 354-357.
12. Inagi R, Miyata T, Imasawa T et al. Mesangial cell-predominant gene, megsin. Nephrol Dial Transplant. 2002; 17 (Suppl 9): 32-33.
13. Lee HS, Lee MS, Lee SM et al. Histological grading of IgA nephropathy predicting renal outcome: Revisiting H.S. Lee's glomerular grading system. Nephrol Dial Transplant. 2005; 20: 342-348.
14. Li YJ, Du Y, Li CX et al. Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3′ untranslated region of the Megsin gene. J Am Soc Nephrol. 2004; 15: 1739-1743.
15. Ohtsubo S, Iida A, Nitta K et al. Association of a single-nucleotide polymorphism in the immunoglobulin mu-binding protein 2 gene with immunoglobulin A nephropathy. J Hum Genet. 2005; 50: 30-35.
16. Ostendorf T, Kanter U, Groene HJ etal. Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol. 2001; 12: 909-918.
17. Panzer U, Schneider A, Steinmetz OM et al. The chemokine receptor 5 Delta32 mutation is associated with increased renal survival in patients with IgA nephropathy. Kidney Int. 2005; 67: 75-81.
18. Schena FP. Immunogenetic aspects of primary IgA nephropathy. Kidney Int. 1995; 48: 1998-2013.
19. Schena FP, D'Altri C, Cerullo G et al. ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis. Kidney Int. 2001; 60: 732-740.
20. Schena FP, Cerullo G, Rossini M et al. Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol. 2002; 13: 453-460.
21. Suzuki H, Suzuki Y, Yamanaka T et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J Am Soc Nephrol. 2005; 16: 1289-1299.
22. Thibaudin L, Berthoux P, Thibaudin D et al. G protein beta3 subunit C825T polymorphism in primary IgA nephropathy. Kidney Int. 2004; 66: 322-328.